Forward progress Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest BPC 157: The Body Protection Compound Revolutionizing Regenerative Medicine 503Pharma The Peptide Craze Ground Truths BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved